RINVOQ tablets 45mg (Upadacitinib hydrate), manufactured by AbbVie (YJ code: 3999048G4027, standard: 45mg 1 tablet), is a Janus kinase (JAK) inhibitor. It is used in adults and some pediatric patients for various inflammatory conditions, including moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, ulcerative colitis, and Crohn’s disease.
RINVOQ tablets 45mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
